Phio Pharmaceuticals Corp.
public$PHIO View Live Feed →
Total Raised
--
Contracts
--
Patents
1
PAC Giving
--
Government Contracts & Awards
No recent government contracts or awards found.
Proprietary Tech & Patents
CHEMICALLY MODIFIED OLIGONUCLEOTIDES TARGETING BROMODOMAIN CONTAINING PROTEIN 4 (BRD4) FOR IMMUNOTHERAPY
US 12753407 Oct 6, 2026
Form D Funding
No recent SEC Form D filings found.
Market Intelligence & News
No recent news or market intelligence found for this entity.
Congressional Trades in $PHIO
No disclosed congressional trades found in $PHIO.
Insider Trades (Form 4)
BUYDirector
Plott Ronald Todd
$10,35010,000 shares Sep 30, 2026
GRANTChief Financial Officer
Carson Lisa Cabott
108,000 shares Sep 29, 2026
GRANTChairman, Pres. & CEO
Bitterman Robert J
400,000 shares Sep 29, 2026
GRANTDirector
Plott Ronald Todd
17,000 shares Sep 29, 2026
BUYDirector
BRADFORD PATRICIA A
$6,5836,500 shares Sep 25, 2026
BUYDirector
Plott Ronald Todd
$17,10015,000 shares Aug 20, 2026
Key People
Bitterman Robert J
Chairman, Pres. & CEO
BoardInsider
Carson Lisa Cabott
Chief Financial Officer
Insider
BRADFORD PATRICIA A
Director
BoardInsider
Plott Ronald Todd
Director
BoardInsider
Political Giving
No disclosed PAC contributions found for this entity.
Factual Connections
Connections to other companies, executives, and politicians — sourced from disclosed trades, shared officers/directors, and public filings — are a Pro/Alpha feature.
Upgrade to Pro